Anne-Marie Fields
Managing Director, PrecisionAQ
Replay available
Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call
Cellectar Biosciences, Inc. (NASDAQ: CLRB) Q4 2025 earnings conference call, held 2026-03-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jim Caruso
President and CEO, Selectar Biosciences
Chad Colleen
Chief Financial Officer, Selectar Biosciences
Jared Loncourt
Chief Operating Officer, Selectar Biosciences
Aydin Azenov
Analyst, Leidenberg
Ted Stankhoff
Analyst, Pfeiffer Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cellectar Biosciences, Inc..
Replay transcript excerpt
WEBVTT 00:00:44.378 -- 00:00:46.378 Thank 00:00:46.830 -- 00:00:48.830 you. 00:01:22.060 -- 00:01:24.060 Thank 00:01:37.784 -- 00:01:39.784 you. 00:03:22.295 -- 00:03:24.295 Thank 00:03:26.721 -- 00:03:28.721 you. 00:04:04.482 -- 00:04:06.482 Thank 00:04:09.850 -- 00:04:11.850 you. 00:05:44.298 -- 00:05:46.298 Thank 00:05:47.009 -- 00:05:49.009 you. 00:06:22.064 -- 00:06:24.064 Thank 00:06:37.787 -- 00:06:39.787 you. 00:07:38.626 -- 00:07:42.852 Ladies and gentlemen, thank you for standing by and welcome. 00:07:42.852 -- 00:07:46.877 At this time, all participants are in listen-only mode. 00:07:46.877 -- 00:07:50.682 Following the presentation, there will be a question and answer session. 00:07:50.682 -- 00:07:54.527 Please be advised that today's conference call may be recorded. 00:07:54.527 -- 00:07:59.534 I would now like to hand the conference call over to Anne-Marie Fields, Managing Director 00:07:59.534 -- 00:08:03.016 at PrecisionAQ. Please go ahead. 00:08:03.199 -- 00:08:07.846 Thank you, Operator. Good morning, and welcome to Selectar Biosciences' fourth quarter 00:08:07.846 -- 00:08:12.834 and full year 2025 financial results and business update conference call. 00:08:12.834 -- 00:08:17.842 Joining us today from Selectar are Jim Caruso, President and CEO, who will provide an 00:08:17.842 -- 00:08:22.891 overview of the company's progress before turning the call over to Chad Colleen, CFO, 00:08:22.891 -- 00:08:26.317 for a financial review of the quarter and the year. 00:08:26.317 -- 00:08:31.240 Following this, Jared Loncourt, Chief Operating Officer, will give an update on the company's 00:08:31.240 -- 00:08:36.627 progress and plans for its promising clinical development pipeline of radiopharmaceuticals. 00:08:36.627 -- 00:08:41.374 Selectar issued a rele...